Accelerated Development of Appropriate Patient Therapies
a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes
On March 21st and 22nd, ADAPT SMART held its closing meeting at the Hungarian Academy of Sciences in Budapest, highlighting the programme’s achievements and next steps for delivery after the project’s conclusion.
This report highlights the main outcomes of the General Assembly of the IMI ADAPT SMART consortium, which was co-chaired by Hans-Georg Eichler (EMA), Solange Rohou (AstraZeneca) and André Broekmans (Lygature).
On Friday September 4th, 2015, a coalition of 90 European healthcare stakeholders from 32 organisations including patients, payers, regulators, HTAs, academic institutions, and industry took their first steps towards investigating MAPPs tools and methodologies, and engaging in a dialogue with all relevant stakeholders to prove and develop workable MAPPs concepts.
The project overview of ADAPT SMART (Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes) provides information regarding participants, objectives, expected impact, and a work plan, among other details.
